Diet Drug Gets Another Chance

Diet drugs have not impressed American governmental health regulators in the last few years with numerous prospective medications having not been given approval and a further diet drug having been removed from the market.
The future of Qnexa, a new diet pill, lies with the FDA, with a meeting next Wednesday will decide the fate of this pill.
This will be the second time that the Food and Drug Administration is going to be hearing evidence for or against approving Qnexa.
The weight loss medication was denied approval in October 2010; the FDA cited possible safety problems.
Nonetheless, the FDA stated that Vivus, its manufacturer, needs to provide additional data as to whether or not the medication can cause birth defects and, if so, which ones.
Furthermore, the FDA has also asked for data on whether or not the slight increase in heart rate linked to this drug increases the risk of cardiovascular events, like heart attacks and stroke.